A new writing in Science has been published, Nervous System Consequences of COVID 19. In this writing authors discuss an array of symptoms such as frequent headaches, intractable fatigue, sensory disturbances, autonomic dysfunction, depression, psychological impacts, and in severe cases, delusions and paranoia, that may persist for months after initial infection, now called Long COVID. […]
Search Results for: COVID
LDA-Columbia Lyme Conf. Videos/Help LDA/Bb in Alzheimer’s Brain/Tick Sugar/Columbia CTN/Bb in SD/Bait Boxes/ILADS Jumbotron/I. Scapularis & Lizards/AR Community Scientists/Hopkins Dashboard/COVID
LDA has released for public on LDA’s YouTube Channel, lectures from the LDA-Columbia 21 st Annual Lyme & Tick-borne Diseases 2021 CME Conference. See lectures by Drs. Aucott, Baranchuk, Breitschwerdt, Brissette, Ericson, Fallon, Lewis, Liegner, and Maggi.
New Lyme & TBD Pregnancy Treatments/21st Annual Lyme & TBD Conf. Completed/President’s Blog: Why Patients Need Gov. Investigation/TBD Risk for Transplant & Transfusion Recipients/Cognitive Impairment After COVID/LDA #GivingTuesday, Nov 6 thru Dec 6
In a recently published review article,* authors provide a comprehensive summary of treatment options for pregnant patients with less common bacterial, fungal, and viral infections, including several tick-borne diseases (Lyme disease, ehrlichiosis, human granulocytic anaplasmosis, human monocytic ehrlichiosis, babesiosis, and Rocky Mountain spotted fever). This review provides guidance to clinicians based on the most recently published evidence-based research and expert recommendations.
A study published in JAMA Network Open examined the cognitive function in patients following COVID-19 Infection. The researchers analyzed data from a cohort of COVID-19 patients from April 2020 through May 2021 and investigated rates of cognitive impairment in survivors who were treated in outpatient, emergency department, or inpatient hospital settings. Prior studies were hindered by limited sample sizes and substandard evaluation of cognitive functioning.
Ticks & Biowarfare Investigation Passes House/Last Chance to Register for LDA Conf. Before Price Increase/COVID Impacts on Lyme Reporting/Monoclonal Antibody COVID Treatment/LDA Doctor Referral Now Open/Valneva Lyme Vaccine
The Lyme Disease Association announces that the House voted this week to pass a number of amendments to the NDAA, National Defense Authorization Act, including a Congressman Chris Smith amendment.
NC Department of Health and Human Services has offered information advising how patients can locate services for monoclonal antibodies treatment for COVID-19 infections. The NCDHHS website states, “The Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) to allow the use of monoclonal antibody therapies for the treatment of mild to moderate COVID-19 […]
In a new study published by the CDC, Effects of COVID-19 Pandemic on Reported Lyme Disease, United States, 2020, authors describe how the impacts of COVID-19 might have influenced Lyme disease case reporting in 2020. Investigators explored 4 data sources to assess how the COVID-19 pandemic may have influenced reporting of Lyme disease cases in […]
Register Now for LDA-Columbia Virtual Conf./New LDA Dr. Referral/Cohen TBD Recovery Center Launch/The State of Lyme Disease/Moderna Vs. Pfizer/Organ-Transplant-Derived Ehrlichiosis/B. Mayonii on Blood Smear/T Cell Exhaustion/COVID in Deer/TBDWG/ABEM
The Lyme Disease Association Inc. and Columbia University Vagelos College of Physicians & Surgeons are jointly providing the 21st annual CME scientific conference, Lyme & Other Tick-Borne Diseases: Research for a Cure, virtually, on October 2, 2021. This conference is designed to meet the high standards for continuing medical education credits for medical & health professionals and researchers.
Findings of a recent study, Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence, show that Moderna’s COVID-19 vaccine appears to have a higher effectiveness rate compared with the Pfizer vaccine. This observational study was conducted from a Minnesota patient cohort in July 2021. Both vaccines appeared to […]
In a recent study conducted by the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) serum samples were analyzed from free-ranging white-tailed deer for SARS-CoV-2 antibodies. Researchers found that a cohort of white-tailed deer populations from Illinois, Michigan, New York, and Pennsylvania were exposed to SARS-CoV-2. The USDA-APHIS has published an […]